These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37321062)

  • 1. A DFT approach for finding therapeutic potential of graphyne as a nanocarrier in the doxorubicin drug delivery to treat cancer.
    Perveen M; Noreen L; Waqas M; Mehmood RF; Iqbal J; Manzoor S; Nazir S; Shawky AM; Khera RA
    J Mol Graph Model; 2023 Nov; 124():108537. PubMed ID: 37321062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled supramolecular interactions for targeted release of Amiodarone drug through Graphyne to treat cardiovascular diseases: An in silico study.
    Perveen M; Hadia NMA; Noreen A; Mehmood RF; Nasr S; Yahia IS; Khera RA; Iqbal J
    J Mol Graph Model; 2023 Jun; 121():108452. PubMed ID: 36963305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy.
    Zhang P; Li J; Ghazwani M; Zhao W; Huang Y; Zhang X; Venkataramanan R; Li S
    Biomaterials; 2015 Oct; 67():104-14. PubMed ID: 26210177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 6. Ab initio study for superior sensitivity of graphyne nanoflake towards nitrogen halides over ammonia.
    Sajid H; Khan S; Ayub K; Amjad Gilani M; Mahmood T; Farooq U; Akhter MS
    J Mol Model; 2022 May; 28(6):161. PubMed ID: 35597854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
    Zhou T; Zhou X; Xing D
    Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of graphitic carbon nitride as a drug delivery system for cisplatin (anticancer drug): A DFT approach.
    Perveen M; Nazir S; Arshad AW; Khan MI; Shamim M; Ayub K; Khan MA; Iqbal J
    Biophys Chem; 2020 Dec; 267():106461. PubMed ID: 32919257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of phosphorene as doxorubicin nanocarrier: An atomistic view from DFT calculations and MD simulations.
    Esfandiarpour R; Badalkhani-Khamseh F; Hadipour NL
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112513. PubMed ID: 35483255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled supramolecular interaction to enhance the bioavailability of hesperetin to targeted cancer cells through graphyne: a comprehensive
    Khan MA; Iqbal J; Ilyas M; Ayub AR; Zhu Y; Li H
    RSC Adv; 2022 Feb; 12(10):6336-6346. PubMed ID: 35424570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Related Intracellular Signalling Pathways Activated by DOXorubicin/Cyclodextrin-Graphene-Based Nanomaterials.
    Pennisi R; Musarra-Pizzo M; Velletri T; Mazzaglia A; Neri G; Scala A; Piperno A; Sciortino MT
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-guest coupling to potentially increase the bio-accessibility of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by nanocarrier graphyne for brain tumor therapy, a comprehensive quantum mechanics study.
    Khan MA; Kalsoom S; Ayub AR; Ilyas M; Hassan N; Irshad K; Zeshan M; Arshad S; Zahid MN; El-Fattah AA; Iqbal J
    J Mol Graph Model; 2023 Sep; 123():108517. PubMed ID: 37235904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-decorated γ-graphyne as a drug transporting agent for the mercaptopurine chemotherapy drug: a DFT study.
    Pallikkara Chandrasekharan S; Lakshmy S; Sanyal G; Kalarikkal N; Trivedi R; Chakraborty B
    Phys Chem Chem Phys; 2023 Mar; 25(13):9461-9471. PubMed ID: 36930162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide-Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy.
    Du K; Xia Q; Heng H; Feng F
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34599-34609. PubMed ID: 32648735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational study of therapeutic potential of phosphorene as a nano-carrier for drug delivery of nebivolol for the prohibition of cardiovascular diseases: a DFT study.
    Riaz S; Jaffar K; Perveen M; Riaz A; Nazir S; Iqbal J
    J Mol Model; 2021 Sep; 27(10):306. PubMed ID: 34590181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
    Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
    Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysinated Multiwalled Carbon Nanotubes with Carbohydrate Ligands as an Effective Nanocarrier for Targeted Doxorubicin Delivery to Breast Cancer Cells.
    Thakur CK; Neupane R; Karthikeyan C; Ashby CR; Babu RJ; Boddu SHS; Tiwari AK; Moorthy NSHN
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.